de Heer K - Search Results

1

[Systematic diagnosis of erythrocytosis].

de Heer K, Silbermann MH, Koene HR, Biemond BJ, Muller HP, van Oers MH. de Heer K, et al. Ned Tijdschr Geneeskd. 2007 Aug 11;151(32):1770-6. Ned Tijdschr Geneeskd. 2007. PMID: 17822247 Review. Dutch.

2

Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis.

de Heer K, Kok MG, Fens N, Weersink EJ, Zwinderman AH, van der Schee MP, Visser CE, van Oers MH, Sterk PJ. de Heer K, et al. J Clin Microbiol. 2016 Mar;54(3):569-75. doi: 10.1128/JCM.02214-15. Epub 2015 Dec 16. J Clin Microbiol. 2016. PMID: 26677251 Free PMC article.

3

Correction for de Heer et al., Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis.

de Heer K, Kok MGM, Fens N, Weersink EJM, Zwinderman AH, van der Schee MPC, Visser CE, van Oers MHJ, Sterk PJ. de Heer K, et al. J Clin Microbiol. 2016 Jul;54(7):1926. doi: 10.1128/JCM.00748-16. J Clin Microbiol. 2016. PMID: 27343292 Free PMC article. No abstract available.

4

eNose technology can detect and classify human pathogenic molds in vitro: a proof-of-concept study of Aspergillus fumigatus and Rhizopus oryzae.

de Heer K, Vonk SI, Kok M, Kolader M, Zwinderman AH, van Oers MH, Sterk PJ, Visser CE. de Heer K, et al. J Breath Res. 2016 Jul 22;10(3):036008. doi: 10.1088/1752-7155/10/3/036008. J Breath Res. 2016. PMID: 27447026

5

Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography-mass spectrometry.

Gerritsen MG, Brinkman P, Escobar N, Bos LD, de Heer K, Meijer M, Janssen HG, de Cock H, Wösten HAB, Visser CE, van Oers MHJ, Sterk PJ. Gerritsen MG, et al. Among authors: de heer k, de cock h. Med Mycol. 2018 Feb 1;56(2):253-256. doi: 10.1093/mmy/myx035. Med Mycol. 2018. PMID: 28525576 Clinical Trial.

6

[Chest X-ray in patients with fever and no localizing symptoms?].

Pereverzeva E, de Stoppelaar SF, de Heer K. Pereverzeva E, et al. Among authors: de stoppelaar sf, de heer k. Ned Tijdschr Geneeskd. 2019 Jul 18;163:D3780. Ned Tijdschr Geneeskd. 2019. PMID: 31361410 Dutch.

7

Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.

Gaartman AE, Sayedi AK, Gerritsma JJ, de Back TR, van Tuijn CF, Tang MW, Heijboer H, de Heer K, Biemond BJ, Nur E. Gaartman AE, et al. Among authors: de heer k, de back tr. Br J Haematol. 2021 Sep;194(5):899-907. doi: 10.1111/bjh.17696. Epub 2021 Jul 15. Br J Haematol. 2021. PMID: 34263922 Free PMC article.

8

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.

Eichhorst B, Niemann CU, Kater AP, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber PB, Tadmor T, Lindström V, da Cunha-Bang C, Schneider C, Poulsen CB, Illmer T, Schöttker B, Nösslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, van der Klift M, Jäger U, Leys MBL, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink JC, Widmer A, Simon F, De Silva N, Fink AM, Bahlo J, Fischer K, Wendtner CM, Kreuzer KA, Ritgen M, Brüggemann M, Tausch E, Levin MD, van Oers M, Geisler C, Stilgenbauer S, Hallek M; GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. Eichhorst B, et al. N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093. N Engl J Med. 2023. PMID: 37163621 Clinical Trial.

9

Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.

de Jonge AV, Duetz C, Bruins WSC, Korst CLBM, Rentenaar R, Cosovic M, Eken M, Twickler I, Nijland M, van der Poel MWM, de Heer K, Klerk CPW, Strobbe L, Oosterveld M, Boersma R, Koene HR, Roemer MGM, van Werkhoven E, Chamuleau MED, Mutis T. de Jonge AV, et al. Among authors: de heer k. Blood Adv. 2024 Mar 12;8(5):1094-1104. doi: 10.1182/bloodadvances.2023011687. Blood Adv. 2024. PMID: 38191686 Free PMC article.

10

Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.

Leeksma AC, Taylor J, Wu B, Gardner JR, He J, Nahas M, Gonen M, Alemayehu WG, Te Raa D, Walther T, Hüllein J, Dietrich S, Claus R, de Boer F, de Heer K, Dubois J, Dampmann M, Dürig J, van Oers MHJ, Geisler CH, Eldering E, Levine RL, Miller V, Mughal T, Lamanna N, Frattini MG, Heaney ML, Zelenetz A, Zenz T, Abdel-Wahab O, Kater AP. Leeksma AC, et al. Among authors: de heer k, de boer f. Leukemia. 2019 Feb;33(2):390-402. doi: 10.1038/s41375-018-0215-9. Epub 2018 Jul 23. Leukemia. 2019. PMID: 30038380 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page